Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep 12;175(6):587-90.
doi: 10.1503/cmaj.060328.

Incidence and causes of severe neonatal hyperbilirubinemia in Canada

Michael Sgro  1 , Douglas Campbell, Vibhuti Shah
Affiliations

Incidence and causes of severe neonatal hyperbilirubinemia in Canada

Michael Sgro et al. CMAJ. .

Abstract

Background: Severe hyperbilirubinemia is the most common cause of neonatal readmission to hospital in Canada even though, in the majority of cases, risk factors can be identified before discharge. Severe neonatal hyperbilirubinemia and kernicterus continue to be reported worldwide in otherwise healthy term infants. We conducted this study to estimate the incidence of severe neonatal hyperbilirubinemia in Canada and to determine underlying causes, improved knowledge of which would be valuable to help identify strategies for risk reduction.

Methods: Data on term infants 60 days of age and younger with unconjugated hyperbilirubinemia were collected prospectively through the Canadian Paediatric Surveillance Program from 2002 to 2004. Infants were included if they had a peak serum total bilirubin level of more than 425 micromol/L or underwent an exchange transfusion. Infants with rhesus iso-immunization or who were born at less than 36 weeks' gestation were excluded.

Results: Of 367 cases reported, 258 were confirmed to be severe neonatal hyperbilirubinemia, for an estimated incidence of 1 in 2480 live births. Causes were identified in 93 cases and included ABO incompatibility (n = 48), glucose-6-phosphate dehydrogenase deficiency (n = 20), other antibody incompatibility (n = 12) and hereditary spherocytosis (n = 7). The mean peak bilirubin level reported was 471 micromol/L (standard deviation [SD] 76 micromol/L, range 156-841 micromol/L). Fifty-seven infants (22.1%) underwent an exchange transfusion. A total of 185 infants (71.7%) were readmitted to hospital, 121 (65.4%) of them within 5 days of age.

Interpretation: Severe neonatal hyperbilirubinemia continues to occur frequently in Canada. In the majority of cases, the underlying cause was not identified. The high readmission rate within days after initial discharge indicates a need for a more thorough assessment of newborn infants and consideration of strategies to identify at-risk newborns, such as predischarge measurement of serum bilirubin levels.

PubMed Disclaimer

Figures

None
Fig. 1: Age of readmission for discharged infants.
See this image and copyright information in PMC

Comment in

References

    1. Tan-Dy C, Moore A, Satodia P, et al. Predicting kernicterus in severe unconjugated hyperbilirubinemia. Paediatr Child Health 2004;9(Suppl A):17A.
    1. Lee K, Perlman M. The impact of early obstetric discharge on newborn health care. Curr Opin Pediatr 1996;8:96-101. - PubMed
    1. Lee K, Perlman M, Ballantyne M, et al. Association between duration of neonatal hospital stay and readmission rate. J Pediatr 1995;127:758-66. - PubMed
    1. Liu S, Wen SW, McMillan D, et al. Increased neonatal readmission rate associated with decreased length of hospital stay at birth in Canada. Can J Public Health 2000;91:46-50. - PMC - PubMed
    1. Brown AK, Damusk K, Kim MH, et al. Factors relating to readmission of term and near-term neonates in the first two weeks of life. J Perinat Med 1999;27:263-75. - PubMed

Publication types